PLAGL1 and subependymoma: Contrary to subependymomas, NET-PLAGL1 seem to be more cellular and may correspond to the tumor type “mixed ependymomas–subependymomas” terminology, found in the current WHO classification [21], which poses a problem for grading and prognosis.